Open | - |
Close | - |
Volume / Avg. | 805.000 / 10.663M |
Day Range | - - - |
52 Wk Range | 0.485 - 2.130 |
Market Cap | $221.986M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 10.39% |
Days to Cover | 3.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Agenus (NASDAQ: AGEN) through any online brokerage.
Other companies in Agenus’s space includes: FibroGen (NASDAQ:FGEN), Inovio Pharmaceuticals (NASDAQ:INO), Gritstone Bio (NASDAQ:GRTS), Mesoblast (NASDAQ:MESO) and INmune Bio (NASDAQ:INMB).
The latest price target for Agenus (NASDAQ: AGEN) was reported by B. Riley Securities on Monday, March 18, 2024. The analyst firm set a price target for 5.00 expecting AGEN to rise to within 12 months (a possible 843.57% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Agenus (NASDAQ: AGEN) is $0.5299 last updated Today at March 19, 2024 at 5:43 AM EDT.
There are no upcoming dividends for Agenus.
Agenus’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Agenus.
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.